Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph Burkhart

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Molecular Pharmacology|August 16, 2002
Covalent binding of the nitroso metabolite of sulfamethoxazole leads to toxicity and major histocompatibility complex-restricted antigen presentationDean J Naisbitt, John Farrell, S Fraser Gordon, et al.
Anesthesia and Analgesia|August 5, 2014
Serum anticholinergic activity and postoperative cognitive dysfunction in elderly patientsAriane Rossi, Christoph Burkhart, Salome Dell-Kuster, et al.
The Journal of Allergy and Clinical Immunology|May 21, 2013
Transient targeting of phosphoinositide 3-kinase acts as a roadblock in mast cells' route to allergyEmilie Collmann, Thomas Bohnacker, Romina Marone, et al.
Bioorganic & Medicinal Chemistry Letters|November 7, 2016
Discovery of novel pyrrolidineoxy-substituted heteroaromatics as potent and selective PI3K delta inhibitors with improved physicochemical propertiesKlemens Hoegenauer, Nicolas Soldermann, Christina Hebach, et al.
ACS Medicinal Chemistry Letters|September 27, 2017
Discovery of CDZ173 (Leniolisib), Representing a Structurally Novel Class of PI3K Delta-Selective InhibitorsKlemens Hoegenauer, Nicolas Soldermann, Frédéric Zécri, et al.
ACS Medicinal Chemistry Letters|August 27, 2016
Discovery and Pharmacological Characterization of Novel Quinazoline-Based PI3K Delta-Selective InhibitorsKlemens Hoegenauer, Nicolas Soldermann, Frédéric Stauffer, et al.
Journal of Medicinal Chemistry|December 8, 2025
Harnessing Glutamine-117 Plasticity toward Structure-Based Identification of Triazole IL-17 InhibitorsMatthias R Bauer, Juraj Velcicky, Alban Goetz, et al.
The Journal of Clinical Investigation|August 9, 2008
The PKC inhibitor AEB071 may be a therapeutic option for psoriasisHans Skvara, Markus Dawid, Elise Kleyn, et al.
Chemmedchem|December 23, 2024
Thiazole-Based IL-17 Inhibitors Discovered by Scaffold MorphingJuraj Velcicky, Estelle Ngo, Matthias R Bauer, et al.
Blood|October 4, 2017
Effective "activated PI3Kδ syndrome"-targeted therapy with the PI3Kδ inhibitor leniolisibV Koneti Rao, Sharon Webster, Virgil A S H Dalm, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Molecular Pharmacology|August 16, 2002
Covalent binding of the nitroso metabolite of sulfamethoxazole leads to toxicity and major histocompatibility complex-restricted antigen presentationDean J Naisbitt, John Farrell, S Fraser Gordon, et al.
Anesthesia and Analgesia|August 5, 2014
Serum anticholinergic activity and postoperative cognitive dysfunction in elderly patientsAriane Rossi, Christoph Burkhart, Salome Dell-Kuster, et al.
The Journal of Allergy and Clinical Immunology|May 21, 2013
Transient targeting of phosphoinositide 3-kinase acts as a roadblock in mast cells' route to allergyEmilie Collmann, Thomas Bohnacker, Romina Marone, et al.
Bioorganic & Medicinal Chemistry Letters|November 7, 2016
Discovery of novel pyrrolidineoxy-substituted heteroaromatics as potent and selective PI3K delta inhibitors with improved physicochemical propertiesKlemens Hoegenauer, Nicolas Soldermann, Christina Hebach, et al.
ACS Medicinal Chemistry Letters|September 27, 2017
Discovery of CDZ173 (Leniolisib), Representing a Structurally Novel Class of PI3K Delta-Selective InhibitorsKlemens Hoegenauer, Nicolas Soldermann, Frédéric Zécri, et al.
ACS Medicinal Chemistry Letters|August 27, 2016
Discovery and Pharmacological Characterization of Novel Quinazoline-Based PI3K Delta-Selective InhibitorsKlemens Hoegenauer, Nicolas Soldermann, Frédéric Stauffer, et al.
Journal of Medicinal Chemistry|December 8, 2025
Harnessing Glutamine-117 Plasticity toward Structure-Based Identification of Triazole IL-17 InhibitorsMatthias R Bauer, Juraj Velcicky, Alban Goetz, et al.
The Journal of Clinical Investigation|August 9, 2008
The PKC inhibitor AEB071 may be a therapeutic option for psoriasisHans Skvara, Markus Dawid, Elise Kleyn, et al.
Chemmedchem|December 23, 2024
Thiazole-Based IL-17 Inhibitors Discovered by Scaffold MorphingJuraj Velcicky, Estelle Ngo, Matthias R Bauer, et al.
Blood|October 4, 2017
Effective "activated PI3Kδ syndrome"-targeted therapy with the PI3Kδ inhibitor leniolisibV Koneti Rao, Sharon Webster, Virgil A S H Dalm, et al.
Pageof 3